Novartis’s Cosentyx Secures Qualified Win In Hidradenitis Suppurativa

Moving Towards Ten Approvals For Blockbuster

expand
Novartis continues to build Cosentyx franchise • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D